VAXZEVRIA

This brand name is authorized in Austria, Estonia, Spain, Finland, France, Croatia, Ireland, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania

Active ingredients

The drug VAXZEVRIA contains one active pharmaceutical ingredient (API):

1 COVID-19 Vaccine AstraZeneca UNII B6L4N5Z4GH - SARS-COV-2

SARS-CoV-2 Spike glycoprotein (ChAdOx1-S) is a monovalent vaccine composed of a single recombinant, replication-deficient chimpanzee adenovirus (ChAdOx1) vector encoding the S glycoprotein of SARS-CoV-2. The SARS-CoV-2 S immunogen in the vaccine is expressed in the trimeric pre-fusion conformation; the coding sequence has not been modified in order to stabilise the expressed S-protein in the pre-fusion conformation. Following administration, the S glycoprotein of SARS-CoV-2 is expressed locally stimulating neutralising antibody and cellular immune responses, which may contribute to protection to COVID-19. Read about SARS-CoV-2 Spike glycoprotein (ChAdOx1-S)

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VAXZEVRIA Suspension for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BN02		J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BN Covid-19 vaccines
Discover more medicines within J07BN02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1836840, 1836851
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1211529001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 553555
Country: FR	Base de données publique des médicaments	Identifier(s): 61875116
Country: JP	医薬品医療機器総合機構	Identifier(s): 631341FA1024
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1091787, 1091788
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 61107
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 22180
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100447040
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67527001, W67527002